Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Liabilities ₹18,661 Cr₹14,925 Cr₹13,309 Cr₹17,566 Cr₹15,397 Cr

What is the latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹18,661 Cr based on Mar2026 Consolidated results.
Year Total Liabilities
Mar2026₹18,661 Cr
Mar2025₹14,925 Cr
Mar2024₹13,309 Cr
Mar2023₹17,566 Cr
Mar2022₹15,397 Cr

How is Total Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Liabilities % Change
Mar2026 ₹18,661 Cr
25.03
Mar2025 ₹14,925 Cr
12.15
Mar2024 ₹13,309 Cr
-24.23
Mar2023 ₹17,566 Cr
14.08
Mar2022 ₹15,397 Cr -

Compare Total Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹63,974.7 Cr -0.9% -6.2% 16.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,466.0 Cr -0.8% -5.1% 6.3% Stock Analytics
DIVIS LABORATORIES ₹246,222.0 Cr -3.2% -1.4% 53.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr -1.6% -6% 32.1% Stock Analytics
CIPLA ₹107,447.0 Cr 0% -3.6% -13.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,471.0 Cr 3.1% 8.7% -1.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.9%

-6.2%

16.3%

SENSEX

-0.1%

-2.3%

-10.7%


You may also like the below Video Courses